Login / Signup

Reply to Dorgham et al., "Considering Personalized Interferon Beta Therapy for COVID-19".

Effat Davoudi-MonfaredHossein Khalili
Published in: Antimicrobial agents and chemotherapy (2021)
Keyphrases
  • coronavirus disease
  • sars cov
  • dendritic cells
  • respiratory syndrome coronavirus
  • immune response